BMRN

BioMarin Pharmaceutical Inc. News Headlines

$83.29
*  
0.93
1.13%
Get BMRN Alerts
*Delayed - data as of Oct. 31, 2014 13:08 ET  -  Find a broker to begin trading BMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BMRN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
The 5 Most Expensive Drugs in the World
10/26/2014 12:21:02 PM - Motley Fool


Friday's ETF with Unusual Volume: BBH
10/24/2014 3:47:15 PM - BNK Invest


BioMarin Q3 Loss Narrower than Expected, View Raised - Analyst Blog
10/24/2014 1:12:00 PM - Zacks.com


BioMarin Pharmaceutical Inc. (BMRN) Has Risen To A 7-Month High On Q3 News
10/24/2014 9:59:00 AM - RTT News


BioMarin Pharmaceutical Inc. Earnings: Striving to Be a Blockbuster Company
10/23/2014 8:38:59 PM - Motley Fool


BioMarin Pharma Swings To Profit, Revenue Misses Estimate; Lift FY Guidance
10/23/2014 8:09:00 PM - RTT News


Biomarin Pharmaceutical Q3 14 Earnings Conference Call At 4:30 PM ET
10/23/2014 3:00:00 PM - RTT News


After-Hours Earnings Report for October 23, 2014 : MSFT, AMZN, CB, CERN, PFG, KLAC, SWN, EW, BMRN, TV, SRCL, ALTR
10/23/2014 2:00:03 PM - NASDAQ.com News


Will BioMarin (BMRN) Disappoint This Earnings Season? - Analyst Blog
10/21/2014 5:30:00 PM - Zacks.com


Amgen Files Patent Infringement Suit Over Cholesterol Drug
10/17/2014 1:25:00 PM - Dow Jones Business News


A Strange Situation At Retrophin Becomes Even More Bizarre
10/6/2014 7:01:00 PM - Seeking Alpha


BioMarin (BMRN) Faces Threat of Genericization for Kuvan - Analyst Blog
9/25/2014 6:24:00 PM - Zacks.com


3 Best Stocks for Investing in Biotech
9/18/2014 8:35:02 AM - Motley Fool


January 2017 Options Now Available For BioMarin Pharmaceutical (BMRN)
9/15/2014 1:14:08 PM - BNK Invest


Cramer's Mad Money - Where Did The Investors Go? (9/8/14)
9/9/2014 6:35:00 AM - Seeking Alpha


Merck KGaA's Kuvan Effective in Under-4 Year Olds - Analyst Blog
9/5/2014 5:35:00 PM - Zacks.com


Notable Two Hundred Day Moving Average Cross - BMRN
9/5/2014 11:49:58 AM - BNK Invest


Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor - Analyst Blog
9/3/2014 10:10:00 AM - Zacks.com


Can BioMarin Pharmaceutical (BMRN) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
8/27/2014 8:49:00 AM - Zacks.com


7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
8/26/2014 9:56:04 PM - Motley Fool


NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog
8/7/2014 12:40:00 PM - Zacks.com


Why BioMarin Pharmaceutical (BMRN) Could Beat Earnings Estimates Again - Tale of the Tape
8/7/2014 8:52:00 AM - Zacks.com


Cramer's Mad Money - 4 Charts With Fangs (8/4/14)
8/5/2014 5:52:00 AM - Seeking Alpha


BioMarin Q2 Loss Narrower than Expected, Revenue Guidance Up - Analyst Blog
7/31/2014 5:00:00 PM - Zacks.com


Markets end July undecided
7/31/2014 8:42:00 AM - Market Intelligence Center